Medicare Enrolled

Dr. Wes Lee, M.D.

Hematology · Santa Rosa, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3555 ROUND BARN CIR, Santa Rosa, CA 95403
7075281050
In practice since 2006 (19 years)
NPI: 1376633149 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lee? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lee

Dr. Wes Lee is a hematology specialist in Santa Rosa, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lee performed 1,577 Medicare services across 670 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lee received a total of $6,274 from 51 pharmaceutical and/or device companies across 319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 22% volume in CA $6,274 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,577
Medicare services
Top 22% in CA for hematology
670
Unique beneficiaries
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~83 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
650 $149 $485
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
384 $101 $345
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
293 $27 $86
New patient office visit, complex (60-74 min) 87 $180 $591
Prolonged inpatient or observation care, each additional 15 minutes
This code is used for prolonged hospital inpatient or observation care services that extend beyond the total time required for the primary evaluation and management service. It covers each additional 15-minute increment of time spent by the provider.
81 $25 $86
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
52 $99 $266
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
17 $144 $514
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
13 $88 $345
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,274
Total received (2018-2024)
Avg $896/year across 7 years
Top 47% in CA for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
319
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,097 (97.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$177 (2.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$446
2023
$282
2022
$1,236
2021
$1,531
2020
$640
2019
$1,179
2018
$961

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Daiichi Sankyo Inc.
$137
Lilly USA, LLC
$116
Janssen Biotech, Inc.
$107
Merck Sharp & Dohme LLC
$32
AstraZeneca Pharmaceuticals LP
$28
SpringWorks Therapeutics, Inc.
$27
Top 3 companies account for 80.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$528
GlaxoSmithKline, LLC.
$522
E.R. Squibb & Sons, L.L.C.
$438
PFIZER INC.
$339
Novartis Pharmaceuticals Corporation
$320
GENZYME CORPORATION
$317
Merck Sharp & Dohme Corporation
$314
Lilly USA, LLC
$254
Janssen Biotech, Inc.
$250
Genentech USA, Inc.
$230
Pharmacyclics LLC, An AbbVie Company
$211
Alexion Pharmaceuticals, Inc.
$193
Exelixis Inc.
$179
Celgene Corporation
$168
Bayer HealthCare Pharmaceuticals Inc.
$161
Daiichi Sankyo Inc.
$159
Amgen Inc.
$156
Progenics Pharmaceuticals, Inc.
$150
Eisai Inc.
$138
Seagen Inc.
$97
Kite Pharma, Inc.
$91
Takeda Pharmaceuticals U.S.A., Inc.
$74
EMD Serono, Inc.
$73
Taiho Oncology, Inc.
$73
Regeneron Healthcare Solutions, Inc.
$73
Merck Sharp & Dohme LLC
$72
Pharmacyclics LLC, an AbbVie Company
$59
Rigel Pharmaceuticals, Inc.
$59
Astellas Pharma US Inc
$47
Gilead Sciences, Inc.
$44
Incyte Corporation
$38
Foundation Medicine, Inc.
$36
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
Clovis Oncology, Inc.
$33
AbbVie, Inc.
$29
SpringWorks Therapeutics, Inc.
$27
ARRAY BIOPHARMA INC
$27
Array BioPharma Inc.
$24
Ipsen Biopharmaceuticals, Inc
$24
AbbVie Inc.
$23
Myovant Sciences Inc.
$22
Lexicon Pharmaceuticals, Inc.
$22
ADC Therapeutics America, Inc.
$22
Epizyme, Inc.,
$17
Karyopharm Therapeutics Inc.
$17
GE HealthCare
$17
Myriad Genetic Laboratories, Inc.
$16
Jazz Pharmaceuticals Inc.
$15
Seattle Genetics, Inc.
$15
Deciphera Pharmaceuticals Inc.
$15
EISAI INC.
$13
Top 3 companies account for 23.7% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALIMTA · Abraxane · Alecensa · Aliqopa · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · Bavencio · Braftovi · CALQUENCE · CYRAMZA · Cabometyx · DARZALEX · ELITEK · EMEND · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · Enhertu · FOUNDATIONONE · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · INQOVI · INREBIC · Imbruvica · Inrebic · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MOVANTIK · MYLOTARG · Nubeqa · OGSIVEO · OPDIVO · ORGOVYX · PADCEV · PIQRAY · PROMACTA · PYLARIFY · Pomalyst · PreciseTumor · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rubraca · SARCLISA · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VYXEOS · Venclexta · Vitrakvi · XPOVIO · XTANDI · Xermelo · ZEJULA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology specialist in Santa Rosa?
Compare hematologists in the Santa Rosa area by procedure volume, costs, and industry payment transparency.
Browse hematologists nearby

Geographic Context

Hematologists within 10 mi
5
Per 100K population
1.0
County median income
$102,840
Nearest hospital
SUTTER SANTA ROSA REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lee is a clinical cardiology specialist, with above-average Medicare volume (top 22% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lee experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Lee performed 650 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lee receive payments from pharmaceutical companies?
Yes. Dr. Lee received a total of $6,274 from 51 companies across 319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lee's costs compare to other hematologists in Santa Rosa?
Dr. Lee's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →